NCT06338345View on ClinicalTrials.gov

Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2028

Conditions
Cardiogenic ShockPost-cardiac SurgeryCardiac ArrestExtracorporeal Membrane Oxygenation ComplicationInfections
Interventions
DIAGNOSTIC_TEST

Therapeutic drug monitoring of beta-lactam

During the 24 first hours after inclusion, 5 blood samples will be collected to mesure plasmatic concentrations of the studied beta-lactam, of creatinin and of albumin

Trial Locations (5)

21000

CHU Dijon-Bourgogne, Dijon

31059

Hôpital Rangueil - CHU Toulouse, Toulouse

63003

CHU de Clermont Ferrand - Hôpital Gabriel Montpied, Clermont-Ferrand

75013

Aphp Pitie Salpetriere, Paris

76031

CHU ROUEN - Hôpital Charles-Nicolle, Rouen

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT06338345 - Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients | Biotech Hunter | Biotech Hunter